Location History:
- Aichi, JP (2005)
- Nagoya, JP (2002 - 2010)
Company Filing History:
2 out of 3,540 
2 out of 5,463 
Years Active: 2002-2010
Title: Yoshitaka Sekido: Pioneering Patents in Cancer Research
Introduction
Yoshitaka Sekido, a distinguished inventor based in Nagoya, Japan, has made significant contributions to the field of biomedical research. With a total of three patents to his name, Sekido's work focuses on innovative approaches to cancer treatment and diagnostics.
Latest Patents
Sekido's latest patents showcase his commitment to addressing critical health issues. The first patent, titled "SEMA3B Inhibits Tumor Growth and Induces Apoptosis in Cancer Cells," identifies the semaphorin polypeptide SEMA3B as a tumor suppressor. This molecule shows promise in inhibiting tumor growth and inducing apoptosis in cancer cells, offering new methods for treatment and diagnosis. His second patent, concerning "Calcium Channel Proteins," focuses on calcium channel compositions and methods of using them. Specifically, it relates to calcium channel alpha2delta subunits and the nucleic acid sequences encoding them, which are essential for identifying compounds that can modulate calcium channel activity and for potential therapeutic applications.
Career Highlights
Sekido has held prominent positions within renowned institutions, significantly influencing his research contributions. He has collaborated with the University of Texas System and The United States of America as represented by the Department of Health and Human Services. His work exemplifies the integration of scientific research with practical applications, reflecting his dedication to improving health outcomes.
Collaborations
Throughout his career, Sekido has partnered with notable individuals in the research community, including Michael I. Lerman and John Dorrance Minna. These collaborations have enriched his scientific endeavors and facilitated the development of innovative solutions to pressing medical challenges.
Conclusion
Yoshitaka Sekido's innovative contributions in the realm of cancer research underscore his status as a leading inventor. With three patents that offer new insights into tumor suppression and calcium channel functionality, Sekido continues to pave the way for advancements in medical science. His work not only advances our understanding of cancer but also opens doors for developing effective therapeutic strategies.